BioMed Research International

Research Article

Total and Free Serum Sialic Acid Concentration in Liver Diseases

Table 1

The laboratory characteristics of patients with liver diseases and controls.
 MCV
(fL)		PT
(sec)		ALT
(IU/L)		AST
(IU/L)		GGT
(IU/L)		CDT
(mg/L)
C88
80.2–94		12.45
11.7–13.8		16.5
8–39		23
14–39		21.5
8–46		43.3
26.8–61
FL89.3
82–99		10.85* 
10.2–15.6		75.5* 
20–337		43* 
29–136		63* 
34–171		—
AC98.2* 
78–118.2		15* 
7.2–31.7		32* 
8–435		82* 
23–1574		206* 
12–2126		37.9
20.4–75.9
NAC92* 
61.1–108		14.45* 
10.3–27.6		29.5* 
6–115		46
13–146		58* 
12–327		38.75
21.8–57.6
PBC94* 
86–105.8		14.2
9.9–20.3		31* 
15–493		73* 
35–245		142* 
6–336		43.8
23.7–58.4
TH99.1* 
80.3–120		14.7
11–31.4		50* 
7–302		60* 
23–382		216* 
9–4050		44.3
21.8–82.4
CH89.6
77–97.7		12
9.8–17		72* 
12–925		52* 
16–674		44* 
5–105		41.9
29.5–72.3
HCV89.5* 
85–102.1		12.2
10.1–15.5		60* 
19–551		48* 
19–236		75* 
3–898		48.7
27.9–77.8
HBV94.8* 
84.9–97.4		13.1
11–14.5		62* 
28–412		52* 
27–378		53* 
9–221		37.2
20.4–51.9
AIH92* 
87–94		13.2
9.7–20.6		141* 
63–916		160* 
58–460		232* 
111–561		50.5
27–70.73
HCC90.9
76–104.4		12.65
11–16.6		43* 
6–194		84* 
30–304		182* 
81–1175		39.7
24.4–102
HCC + C96.8* 
85–98		17.6* 
12.4–20		20.5
6–119		79* 
35–195		141* 
53–554		46
25–76.6
AHB86.6
78.3–90		13.8
11.8–14.5		831.5* 
726–1774		680.5* 
125–1972		231* 
168–453		—
Data are median and ranges. MCV: mean corpuscular volume, PT: prothrombin time, ALT: alanine aminotransferase, AST: aspartate aminotransferase, GGT: gamma glutamyltransferase, CDT: carbohydrate-deficient transferrin, C: controls, FL: fatty liver, AC: alcoholic cirrhosis, NAC: nonalcoholic cirrhosis, PBC: primary biliary cirrhosis, TH: toxic hepatitis, CH: chronic nonviral hepatitis, HCV: chronic viral hepatitis C, HBV: chronic viral hepatitis B, AIH: autoimmune hepatitis, HCC: primary liver cancer, HCC + C: primary liver cancer and cirrhosis, and AHB: acute hepatitis B.
*Significant differences in comparison to the control group.